Tumour characteristics, treatment patterns and survival of patients aged 80 years or older with colorectal cancer. (March 2015)

• Record Type: Journal Article
• Authors: Kotake, K.; Asano, M.; Ozawa, H.; Kobayashi, H.; Sugihara, K.
• Is Part Of: Colorectal disease. Volume 17:Number 3(2015)
• Page Start: 205
• Page End: 215
• Publication Date: 2015-03
• Subjects: Colon (Anatomy) -- Diseases -- Periodicals; Rectum -- Diseases -- Periodicals; 616.34
• DOI: 10.1111/codi.12826
• Languages: English
• ISSNs: 1462-8910

Abstract

<abstract abstract-type="main" id="codi12826-abs-0001"> <title>Abstract</title> <sec id="codi12826-sec-0001" sec-type="section"> <title>Aim</title> <p>This study aimed to clarify tumour characteristics and treatment patterns for patients with colorectal cancer aged 80 years or older and the impact of age on survival using a large‐scale cancer registry database.</p> </sec> <sec id="codi12826-sec-0002" sec-type="section"> <title>Method</title> <p>The database was used to identify 40 851 colorectal cancer patients who underwent surgery between 1995 and 2004. Patients were stratified into four age groups (< 50, 50–64, 65–79, ≥ 80 years). Demographics, tumour characteristics, treatment pattern and survival were compared between age groups. Additionally, the impact of lymph node dissection and adjuvant chemotherapy on survival was studied using the propensity score‐matching method.</p> </sec> <sec id="codi12826-sec-0003" sec-type="section"> <title>Results</title> <p>In the over 80 age group, patients were more commonly female, with right colon cancer, multiple primary cancers, history of colorectal cancer, high serum carcinoembryonic antigen values, large tumour, undifferentiated histology, and more frequent pT3/pT4 tumours. In contrast, metastatic disease, central lymph node dissection and adjuvant chemotherapy were less frequent. Overall survival and cancer‐specific survival decreased with increasing age for any stage. Multivariate analysis showed age to be an independent predictor of overall survival (hazard ratio 1.45, 95% CI 1.34–1.58, <italic>P</italic> < 0.001). In the propensity score‐matched cohort, overall survival of the patients with central node dissection and having adjuvant chemotherapy was significantly better than for those without. This difference was not statistically significant in patients aged 80 and above.</p> </sec> <sec id="codi12826-sec-0004" sec-type="section"> <title>Conclusion</title> <p>This study showed a significant difference in tumour characteristics and treatment patterns in patients aged 80 and above. Even after adjustment for clinicopathological factors, the difference in survival persisted and age was considered a robust prognostic factor.</p> </sec> </abstract>